Active Ingredient(s):Doravirine + Lamivudine + Tenofovir Disoproxil Fumarate FDA Approved: * August 30, 2018 Pharm Company: *MSD MERCK CO Category:HIV / AIDS
Doravirine/lamivudine/tenofovir, sold under the brand name Delstrigo, is a fixed-dose combination antiretroviral medication for the treatment of HIV/AIDS. It contains doravirine, lamivudine, and tenofovir disoproxil. It is taken by mouth.
In the United States, it was approved by the Food and Drug Administration (FDA) for the treatment of HIV-1 infection in August 2018.[6&...
* May have multiple approval dates, manufacturers, or labelers.